CancerExeliris and Lin Gang Laboratory identify new PI3Kα inhibitorsExeliris Co. Ltd. and Lin Gang Laboratory have reported phosphatidylinositol 3-kinase α (PI3Kα) inhibitors that are potentially useful for the treatment of cancer.